Author

Tatjana Zabelina

Observed names: T Zabelina, T. Zabelina, Tatiana M. Zabelina, Zabelina T., Zabelina, T., Zabelina, Tatjana

Institution: University Medical Center Hamburg-Eppendorf

Observed institutions: Universität Hamburg, First Pavlov State Medical University of St. Petersburg, Sheba Medical Center, Deutsche Klinik für Diagnostik, Assistance Publique – Hôpitaux de Paris, University Medical Center Hamburg-Eppendorf, Ministry of Health of the Russian Federation, University Cancer Center Hamburg, National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation, Jena University Hospital, Hôpital Saint-Louis, University Hospital Carl Gustav Carus, Friedrich Schiller University Jena, Charité - Universitätsmedizin Berlin

ORCID: 0009-0005-0344-2669

Observed ORCID: 0009-0005-0344-2669

OpenAlex ID: A5111514659

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

2009 · Nicolaus Kröger, Ernst Holler, et al. · Blood · 396

PDF

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

2002 · Nicolaus Kröger, Rainer Schwerdtfeger, et al. · Blood · 255

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis

2015 · Nicolaus Kröger, Toni Giorgino, et al. · Blood · 186

PDF

2002 · Nicolaus Kröger, Herbert Gottfried Sayer, et al. · Blood · 185

PDF

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis

2006 · Nicolaus Kröger, Anita Badbaran, et al. · Blood · 141

Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings

2012 · N Kröger, T Zabelina, et al. · Leukemia · 135

Pilot study of reduced‐intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis

2005 · Nicolaus Kröger, Tatjana Zabelina, et al. · British Journal of Haematology · 126

PDF

Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

2005 · Nicolaus Kröger, Bronwen Shaw, et al. · British Journal of Haematology · 117

PDF

Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

2010 · Haefaa Alchalby, Anita Badbaran, et al. · Blood · 114

Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents

2010 · M. Schmidt-Hieber, J. Schwender, et al. · Haematologica · 112

PDF

Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma

2004 · Nicolaus Kröger, Avichai Shimoni, et al. · Blood · 112

Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans

2020 · Johana Norona, Petya Apostolova, et al. · Blood · 107

PDF

Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation

2017 · Nicolaus Kröger, Victoria Panagiota, et al. · Transplantation and Cellular Therapy · 106

PDF

JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

2014 · T Stübig, H Alchalby, et al. · Leukemia · 106

Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

2002 · Nicolaus Kröger, Tatjana Zabelina, et al. · British Journal of Haematology · 106

Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma

2004 · Nicolaus Kröger, Jose A. Perez-Simon, et al. · Transplantation and Cellular Therapy · 103

PDF

Low Number of Donor Activating Killer Immunoglobulin-Like Receptors (KIR) Genes but not KIR-Ligand Mismatch Prevents Relapse and Improves Disease-Free Survival in Leukemia Patients After In Vivo T-Cell Depleted Unrelated Stem Cell Transplantation

2006 · Nicolaus Kröger, Thomas Binder, et al. · Transplantation · 100

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

2004 · A Shimoni, N Kröger, et al. · Leukemia · 100

Risk models predicting survival after reduced‐intensity transplantation for myelofibrosis

2012 · Haefaa Alchalby, Dinah‐Rohina Yunus, et al. · British Journal of Haematology · 97

Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation

2018 · Nicolaus Kröger, Sharifah Shahnaz Syed Abd Kadir, et al. · Transplantation and Cellular Therapy · 96

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT

2008 · S Ocheni, N Kroeger, et al. · Bone Marrow Transplantation · 94

Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)

2006 · N Kröger, A Shimoni, et al. · Bone Marrow Transplantation · 94

Allogeneic Stem Cell Transplantation for Myelofibrosis with Leukemic Transformation: A Study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation

2013 · Haefaa Alchalby, Tatjana Zabelina, et al. · Transplantation and Cellular Therapy · 88

PDF

Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

2012 · Nicolaus Kröger, Anita Badbaran, et al. · Transplantation and Cellular Therapy · 88

PDF

Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma

2009 · Nicolaus Kröger, Anita Badbaran, et al. · Experimental Hematology · 86

Works count: 177

Citation count: 5,936

H-index: 48

I10-index: 89